Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, TRI

Yokogawa Fluid Imaging Technologies Announces the Release of a Ground-Breaking New Instrument, the FlowCam + LO


SCARBOROUGH, Maine, July 9, 2020 /PRNewswire-PRWeb/ -- Yokogawa Fluid Imaging Technologies, of Scarborough Maine announced today the release of its newest FlowCam with a fully integrated light obscuration module. By combining industry-standard light obscuration technology required for USP compliance with digital images from proven Flow Imaging Microscopy (FIM) technology, the new FlowCam + LO will soon become the preferred instrument in biopharma labs worldwide.

Measuring and monitoring particulate matter present in injectable drugs is extremely important to companies involved in formulation development, manufacturing, and packaging. Adverse effects caused by protein aggregates and extrinsic particles in these drugs have been well documented over the years. The risks range from reduced efficacy to significant immunogenic responses. Historically, companies have had to rely upon multiple lab instruments to perform analysis of biologics: light obscuration, plus another method like manual microscopy or flow imaging, due to limitations of LO technology. Now there is an option to get FDA-mandated LO results and flow imaging morphology information from a single instrument.

In the FlowCam + LO, a single sample passes continuously through two flow cells. The first uses FlowCam technology to capture digital images of particles ranging from 1µm ? 1mm, and the second uses light obscuration to provide data necessary for USP compliance. Those already using flow imaging microscopy will reduce sample volumes and bench time by combining two instruments and two steps into one.

"Users who are new to flow imaging can now obtain images and morphological data that allow them to interpret the light obscuration data and show them what's underneath the curve, including revealing transparent and translucent protein particles that may have been missed by light obscuration instruments" says Kent Peterson, CEO.

Yokogawa Fluid Imaging Technologies, Inc. manufactures the FlowCam imaging and analysis family of instruments which now encompasses 7 models engineered to analyze particles and organisms ranging in size from 300 nm to 5 mm. The paired intelligent software, VisualSpreadsheet®, utilizes image recognition technology and measures 40+ morphological parameters including biovolume, coloration, shape, and size to classify microscopic particles in a fluid medium.

 

SOURCE Fluid Imaging Technologies


These press releases may also interest you

at 00:39
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...

25 avr 2024
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

25 avr 2024
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

25 avr 2024
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

25 avr 2024
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...



News published on and distributed by: